Zivo Bioscience, Inc. ZIVO US Equity
Zivo Bioscience, Inc. (OTC: ZIVO), an SEC filer in Biological Products, (No Diagnostic Substances), closed at $4.27, +0.0%, on 2026-08-28, with a market cap of $17M as of 2026-08-26 and a net margin of -8513.4%. Institutional ownership, earnings history and filed financials are on the tabs below.
Documents
| Period end | Filed | Form | Read here | EDGAR |
|---|---|---|---|---|
| 2024-12-31 | 2025-03-18 | 10-K | read · risk factors · MD&A | index · original · 0001654954-25-002948 |
| 2023-12-31 | 2024-03-15 | 10-K | read · risk factors · MD&A | index · original · 0001654954-24-003228 |
| 2022-12-31 | 2023-03-14 | 10-K | read · risk factors · MD&A | index · original · 0001654954-23-002845 |
| 2021-12-31 | 2022-04-22 | 10-K | read · risk factors · MD&A | index · original · 0001654954-22-005298 |
| 2020-12-31 | 2021-02-25 | 10-K | read · risk factors · MD&A | index · original · 0001078782-21-000172 |
▾Risk registerwhich risk-factor headings appeared in which year
38 captions · 5 filings
Descriptive and within-name: this is what changed in the wording of one firm's own filings.
| Risk-factor caption | 2020 | 2021 | 2022 | 2023 | 2024 | Years |
|---|---|---|---|---|---|---|
| · | · | · | · | ● | 1 | |
| · | · | · | ● | ● | 2 | |
| · | · | · | ● | ● | 2 | |
| · | · | · | ● | ● | 2 | |
| · | · | ● | ● | ● | 3 | |
| · | · | ● | ● | ● | 3 | |
| · | ● | ● | ● | ● | 4 | |
| · | ● | ● | ● | ● | 4 | |
| · | ● | ● | ● | ● | 4 | |
| · | ● | ● | ● | ● | 4 | |
| · | ● | ● | ● | ● | 4 | |
| · | ● | ● | ● | ● | 4 | |
| · | ● | ● | ● | ● | 4 | |
| · | ● | ● | · | · | 2 | |
| · | ● | ● | · | · | 2 | |
| ● | · | · | · | · | 1 | |
| ● | · | · | · | · | 1 | |
| ● | · | · | · | · | 1 | |
| ● | · | · | · | · | 1 | |
| ● | · | · | · | · | 1 | |
| ● | · | · | · | · | 1 | |
| ● | · | · | · | · | 1 | |
| ● | ● | ● | ● | ● | 5 | |
| ● | ● | ● | ● | ● | 5 rw | |
| ● | ● | ● | ● | ● | 5 | |
| ● | ● | ● | ● | ● | 5 | |
| ● | ● | ● | ● | ● | 5 | |
| ● | ● | ● | ● | ● | 5 rw | |
| ● | ● | ● | ● | ● | 5 | |
| ● | ● | ● | ● | ● | 5 | |
| ● | ● | ● | ● | ● | 5 | |
| ● | ● | ● | ● | ● | 5 | |
| ● | ● | ● | ● | ● | 5 rw | |
| ● | ● | ● | ● | ● | 5 rw | |
| ● | ● | ● | ● | ● | 5 | |
| ● | ● | ● | ● | ● | 5 | |
| ● | ● | ● | ● | ● | 5 | |
| ● | ● | ● | ● | ● | 5 |
The filer's own 10-K text · 5 filings read
Rows are the filing's own headings, verbatim — nothing is summarized or generated.
A blank cell means the filer did not print that heading that year — not that the risk ended.
Gates: 5+ captions · 50% of Item 1A · match at Jaccard 0.6.
▾Filing languagedocument length, negation and hedging — chart it against price on GRAPH
5 filings measured
Descriptive and within-name: this is what changed in the wording of one firm's own filings.
| Filed | Period end | Document words | Item 1A words | Negation / 10k | Hedging / 10k | Filing |
|---|---|---|---|---|---|---|
| 2021-02-25 | 2020-12-31 | 31,148 | 5,622 | 70.31 | 110.76 | read · EDGAR ↗ |
| 2022-04-22 | 2021-12-31 | 32,847 | 6,619 | 63.32 | 127.26 | read · EDGAR ↗ |
| 2023-03-14 | 2022-12-31 | 29,160 | 7,033 | 68.59 | 141.29 | read · EDGAR ↗ |
| 2024-03-15 | 2023-12-31 | 28,556 | 6,715 | 65.49 | 143.23 | read · EDGAR ↗ |
| 2025-03-18 | 2024-12-31 | 31,579 | 6,581 | 59.53 | 135.85 | read · EDGAR ↗ |
plot against the price on GRAPH: Document length · Item 1A length · Negation per 10k words · Hedging per 10k words
The filer's own 10-K text · 5 filings measured
House wordlists, not a licensed dictionary and not tuned against returns.
9 negation words · 40 hedging words — hover to read both lists.
Each point sits at its filing date and is held flat until the next filing.